ArticleTherapeutic advances in gastroenterology2021

Extraintestinal manifestations at baseline, and the effect of tofacitinib, in patients with moderate to severe ulcerative colitis.

David T Rubin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.